Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTNU Intranasal Naloxone Trial
2016-004072-22Phase 3Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Nov 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of naloxone in opioid intoxication, sponsored by Norwegian University of Science and Technology. Primary endpoint: Return of spontaneous respiration within 10 minutes. Started Nov 2016; status: completed.
02
Drugs
naloxone
03
Conditions
opioid intoxication
Beyond the preview
Go deeper on 2016-004072-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004072-22.